These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

909 related articles for article (PubMed ID: 9568807)

  • 1. Irreversible increase of serum IGF-1 and IGFBP-3 levels in GnRH-dependent precocious puberty of different etiologies: implications for the onset of puberty.
    Belgorosky A; Rivarola MA
    Horm Res; 1998; 49(5):226-32. PubMed ID: 9568807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 levels are increased in central precocious puberty: effects of two different treatment regimens with gonadotropin-releasing hormone agonists, without or in combination with an antiandrogen (cyproterone acetate).
    Juul A; Scheike T; Nielsen CT; Krabbe S; Müller J; Skakkebaek NE
    J Clin Endocrinol Metab; 1995 Oct; 80(10):3059-67. PubMed ID: 7559897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 in girls with premature thelarche.
    Sales DS; Moreira AC; Camacho-Hübner C; Ricco RG; Daneluzzi JC; Campos AD; Martinelli CE
    J Pediatr Endocrinol Metab; 2003; 16(6):827-33. PubMed ID: 12948294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum insulin-like growth factor-I (IGF-I) and IGF binding protein-3 levels in children with precocious puberty treated with gonadotropin-releasing hormone analog without or in combination with cyproterone acetate.
    Verrotti A; Ferrari M; Sabatino G; Morgese G; Chiarelli F
    Gynecol Endocrinol; 1997 Aug; 11(4):243-50. PubMed ID: 9272420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between the GH/IGF-I axis, insulin sensitivity, and adrenal androgens in normal prepubertal and pubertal boys.
    Guercio G; Rivarola MA; Chaler E; Maceiras M; Belgorosky A
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1162-9. PubMed ID: 11889181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor-I and IGF binding protein-3 remain high after GnRH analogue therapy in girls with central precocious puberty.
    Kanety H; Karasik A; Pariente C; Kauschansky A
    Clin Endocrinol (Oxf); 1996 Jul; 45(1):7-12. PubMed ID: 8796132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of the pituitary-gonadal axis in children with central precocious puberty: effects on growth, growth hormone, insulin-like growth factor-I, and prolactin secretion.
    Sklar CA; Rothenberg S; Blumberg D; Oberfield SE; Levine LS; David R
    J Clin Endocrinol Metab; 1991 Oct; 73(4):734-8. PubMed ID: 1909701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum concentrations of free and total insulin-like growth factor-I, IGF binding proteins -1 and -3 and IGFBP-3 protease activity in boys with normal or precocious puberty.
    Juul A; Flyvbjerg A; Frystyk J; Müller J; Skakkebaek NE
    Clin Endocrinol (Oxf); 1996 May; 44(5):515-23. PubMed ID: 8762727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproductive axis after discontinuation of gonadotropin-releasing hormone analog treatment of girls with precocious puberty: long term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty.
    Feuillan PP; Jones JV; Barnes K; Oerter-Klein K; Cutler GB
    J Clin Endocrinol Metab; 1999 Jan; 84(1):44-9. PubMed ID: 9920060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The acid-labile subunit of human ternary insulin-like growth factor-binding protein complex in girls with central precocious puberty before and during gonadotropin-releasing hormone analog therapy.
    Cisternino M; Draghi M; Lauriola S; Scarcella D; Bernasconi S; Cavallo L; De Luca F; Lomeo A; Tatò L
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4629-33. PubMed ID: 12364447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overnight levels of luteinizing hormone, follicle-stimulating hormone and growth hormone before and during gonadotropin-releasing hormone analogue treatment in short boys born small for gestational age.
    van der Kaay DC; de Jong FH; Rose SR; Odink RJ; Bakker-van Waarde WM; Sulkers EJ; Hokken-Koelega AC
    Horm Res; 2009; 71(5):260-7. PubMed ID: 19339790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like Growth Factor 1, but Not Insulin-Like Growth Factor-Binding Protein 3, Predicts Central Precocious Puberty in Girls 6-8 Years Old: A Retrospective Study.
    Escagedo PD; Deal CL; Dwyer AA; Hauschild M
    Horm Res Paediatr; 2021; 94(1-2):44-51. PubMed ID: 34098553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of growth hormone binding protein in children with normal and precocious puberty: relation to age, gender, body composition and gonadal steroids.
    Juul A; Fisker S; Scheike T; Hertel T; Müller J; Orskov H; Skakkebaek NE
    Clin Endocrinol (Oxf); 2000 Feb; 52(2):165-72. PubMed ID: 10671943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-year results of treatment with depot leuprolide acetate for central precocious puberty.
    Neely EK; Hintz RL; Parker B; Bachrach LK; Cohen P; Olney R; Wilson DM
    J Pediatr; 1992 Oct; 121(4):634-40. PubMed ID: 1403402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of medroxyprogesterone acetate on gonadotropin secretion in girls with precocious puberty.
    Warren MP; Mathews JH; Morishima A; Vande Wiele R
    Am J Med Sci; 1975; 269(3):375-81. PubMed ID: 1155493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precocious puberty in children with tumours of the suprasellar and pineal areas: organic central precocious puberty.
    Rivarola ; Belgorosky A; Mendilaharzu H; Vidal G
    Acta Paediatr; 2001 Jul; 90(7):751-6. PubMed ID: 11519977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of combined Gn-RH agonist and hGH therapy for better attining the goals in precocious puberty treatment.
    Tatò L; Saggese G; Cavallo L; Antoniazzi F; Corrias A; Pasquino AM; Cisternino M
    Horm Res; 1995; 44 Suppl 3():49-54. PubMed ID: 8719441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sexual dimorphism in the maturation of the pituitary-gonadal axis, assessed by GnRH agonist challenge.
    Potau N; Ibáñez L; Sentis M; Carrascosa A
    Eur J Endocrinol; 1999 Jul; 141(1):27-34. PubMed ID: 10407219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pathophysiology of gonadotropin secretion in patients with idiopathic precocious puberty and follow up studies during and after therapy with medroxyprogesterone acetate (author's transl)].
    Aono T; Minagawa J; Terakawa N; Kurachi K; Matsumoto K
    Nihon Naibunpi Gakkai Zasshi; 1975 Nov; 51(11):898-907. PubMed ID: 1241847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of anthropomorphic and biochemical characteristics in girls with central precocious puberty and thelarche variant.
    Su PH; Wang SL; Chen JY; Chen SJ; Ke JC
    J Pediatr Endocrinol Metab; 2008 Mar; 21(3):213-20. PubMed ID: 18540247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.